Morning Movers 4/5: NADX, AEZS, KERX, SMMX, RPRX, CRAY Higher; ABCW, ERI, ENCO Lower
National Dentex Corporation (NASDAQ: NADX) 68.3% HIGHER; entered into a definitive agreement and plan of merger to be acquired by GDC Holdings, Inc., which is a holding company of GeoDigm Corporation, a technology based manufacturing and laboratory company and a portfolio company of Welsh, Carson, Anderson & Stowe XI, L.P. Under the terms of the merger agreement, National Dentex’s shareholders will receive $17.00 in cash for each share of National Dentex common stock they hold.
Æterna Zentaris Inc. (NASDAQ: AEZS) 30% HIGHER; today announced that its partner, Keryx Biopharmaceuticals (NASDAQ: KERX), was granted Fast Track designation by the U.S. FDA for perifosine (KRX-0401), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, for the treatment of refractory advanced colorectal cancer. Keryx is Æterna Zentaris' partner and licensee for perifosine in the United States, Canada and Mexico. Æterna Zentaris has also out-licensed perifosine to Handok in South Korea while retaining rights for the rest of the world.
Anchor BanCorp Wisconsin Inc. (NASDAQ: ABCW) 29.6% LOWER; today announced it and Badger Anchor Holdings, LLC had mutually agreed to terminate their agreements which granted Badger Holdings exclusivity through March 31, 2010, with respect to negotiating an investment in Anchor. The parties announced the agreements in December 2009, and agreed to terminate them on March 31, 2010.
Keryx Biopharma (Nasdaq: KERX) 24.8% HIGHER; see AEterna Zentaris.
Symyx Technologies, Inc. (NASDAQ: SMMX) 16.3% HIGHER; Accelrys, Inc. (NASDAQ: ACCL) and Symyx announced merger agreement that will establish a new leader in scientific informatics software.
Repros Therapeutics Inc. (NASDAQ: RPRX) 13.3% HIGHER; today announced that the Company has requested a lift of the full clinical hold on its oral drug Proellex being developed for the treatment of uterine fibroids and endometriosis. On August 4, 2009, the FDA noted that further testing of Proellex was placed on full clinical hold due to findings of serious adverse events associated with liver toxicity. Previously, on August 3, 2009, Repros unilaterally suspended its then-ongoing Proellex studies.
Emrise (NYSE: ERI) 12.9% LOWER; last week the stock couldn't hold above the $1 level. The stock sold-off by more than 11% on Thursday of last week.
Cray Inc. (NASDAQ: CRAY) 11.4% HIGHER; today announced that it has signed a sub-contract with Los Alamos National Security, LLC to provide the National Nuclear Security Administration with a next-generation Cray supercomputer. Currently valued at more than $45 million, the multi-year, multi-phase contract can be expanded if the NNSA exercises an option for a future upgrade. The new system will create a new supercomputing platform, named Cielo, for the Advanced Simulation and Computing program at the NNSA.
Encorium Group, Inc. (Nasdaq: ENCO) 10.6% LOWER; announced today that it will file a Form 12b-25 with the Securities and Exchange Commission, which will provide the Company with a 15- calendar day extension for filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2009. The Company's independent registered accounting firm has not completed its audit of the Company's financial statements and has not provided its report and consent for the Company's Annual Report. The Company will file its Form 10-K as soon as its independent registered accounting firm provides its report on those financial statements and its consent.
CalAmp Corp. (NASDAQ: CAMP) 8.7% HIGHER; today announced that its Wireless Networks business has entered into three new supply contracts with an aggregate value of $15.2 million, increasing the backlog of this business to a record level. The three contracts are with customers in the Rail Transportation, Public Safety and Utility Smart Grid sectors. Work on each contract is expected to begin immediately with the majority of the revenues expected to be recognized in the current and next fiscal year.
MDRNA, Inc. (NASDAQ: MRNA) 8.4% HIGHER; today announced a study effort with Pfizer (NYSE: PFE). The relationship will focus on the evaluation of MDRNA's proprietary di-alkylated amino acids (DiLA2) platform and UsiRNA constructs for RNA interference (RNAi). Additional details of the collaboration were not disclosed. This marks MDRNA's fourth early collaborative effort announced with a major pharmaceutical company in the past nine months.
Brush Engineered Materials Inc. (NYSE: BW) 8.3% HIGHER; raises Q1 sales guidance from $275-$295 million to $300-$310 million. Raises its FY10 sales guidance from $1.1-$1.2 billion to $1.2-$1.3 billion and EPS from $0.75-$1.00 to $1.15-$1.40.
Microvision (NASDAQ: MVIS) 8.3% HIGHER; announced today that it has received an $8.5 million purchase order for its new ultra-miniature PicoP laser projection display engine from a consumer electronics customer. The OEM plans to embed the PicoP engine inside a high-end mobile media player for release in late 2010 and plans to announce its launch at that time.
To get this report daily, visit http://www.streetinsider.com/entities/Morning+Movers.
Æterna Zentaris Inc. (NASDAQ: AEZS) 30% HIGHER; today announced that its partner, Keryx Biopharmaceuticals (NASDAQ: KERX), was granted Fast Track designation by the U.S. FDA for perifosine (KRX-0401), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, for the treatment of refractory advanced colorectal cancer. Keryx is Æterna Zentaris' partner and licensee for perifosine in the United States, Canada and Mexico. Æterna Zentaris has also out-licensed perifosine to Handok in South Korea while retaining rights for the rest of the world.
Anchor BanCorp Wisconsin Inc. (NASDAQ: ABCW) 29.6% LOWER; today announced it and Badger Anchor Holdings, LLC had mutually agreed to terminate their agreements which granted Badger Holdings exclusivity through March 31, 2010, with respect to negotiating an investment in Anchor. The parties announced the agreements in December 2009, and agreed to terminate them on March 31, 2010.
Keryx Biopharma (Nasdaq: KERX) 24.8% HIGHER; see AEterna Zentaris.
Symyx Technologies, Inc. (NASDAQ: SMMX) 16.3% HIGHER; Accelrys, Inc. (NASDAQ: ACCL) and Symyx announced merger agreement that will establish a new leader in scientific informatics software.
Repros Therapeutics Inc. (NASDAQ: RPRX) 13.3% HIGHER; today announced that the Company has requested a lift of the full clinical hold on its oral drug Proellex being developed for the treatment of uterine fibroids and endometriosis. On August 4, 2009, the FDA noted that further testing of Proellex was placed on full clinical hold due to findings of serious adverse events associated with liver toxicity. Previously, on August 3, 2009, Repros unilaterally suspended its then-ongoing Proellex studies.
Emrise (NYSE: ERI) 12.9% LOWER; last week the stock couldn't hold above the $1 level. The stock sold-off by more than 11% on Thursday of last week.
Cray Inc. (NASDAQ: CRAY) 11.4% HIGHER; today announced that it has signed a sub-contract with Los Alamos National Security, LLC to provide the National Nuclear Security Administration with a next-generation Cray supercomputer. Currently valued at more than $45 million, the multi-year, multi-phase contract can be expanded if the NNSA exercises an option for a future upgrade. The new system will create a new supercomputing platform, named Cielo, for the Advanced Simulation and Computing program at the NNSA.
Encorium Group, Inc. (Nasdaq: ENCO) 10.6% LOWER; announced today that it will file a Form 12b-25 with the Securities and Exchange Commission, which will provide the Company with a 15- calendar day extension for filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2009. The Company's independent registered accounting firm has not completed its audit of the Company's financial statements and has not provided its report and consent for the Company's Annual Report. The Company will file its Form 10-K as soon as its independent registered accounting firm provides its report on those financial statements and its consent.
CalAmp Corp. (NASDAQ: CAMP) 8.7% HIGHER; today announced that its Wireless Networks business has entered into three new supply contracts with an aggregate value of $15.2 million, increasing the backlog of this business to a record level. The three contracts are with customers in the Rail Transportation, Public Safety and Utility Smart Grid sectors. Work on each contract is expected to begin immediately with the majority of the revenues expected to be recognized in the current and next fiscal year.
MDRNA, Inc. (NASDAQ: MRNA) 8.4% HIGHER; today announced a study effort with Pfizer (NYSE: PFE). The relationship will focus on the evaluation of MDRNA's proprietary di-alkylated amino acids (DiLA2) platform and UsiRNA constructs for RNA interference (RNAi). Additional details of the collaboration were not disclosed. This marks MDRNA's fourth early collaborative effort announced with a major pharmaceutical company in the past nine months.
Brush Engineered Materials Inc. (NYSE: BW) 8.3% HIGHER; raises Q1 sales guidance from $275-$295 million to $300-$310 million. Raises its FY10 sales guidance from $1.1-$1.2 billion to $1.2-$1.3 billion and EPS from $0.75-$1.00 to $1.15-$1.40.
Microvision (NASDAQ: MVIS) 8.3% HIGHER; announced today that it has received an $8.5 million purchase order for its new ultra-miniature PicoP laser projection display engine from a consumer electronics customer. The OEM plans to embed the PicoP engine inside a high-end mobile media player for release in late 2010 and plans to announce its launch at that time.
To get this report daily, visit http://www.streetinsider.com/entities/Morning+Movers.
You May Also Be Interested In
- Unusual 11 Mid-Day Movers 05/25: (GNOM) (UPI) (RPRX) Higher; (TLB) (DCTH) (PAY) Lower
- After-Hours Movers 05/24: (BLOX) (DLPH) (CHK) Higher; (PAY) (NYMT) (SMTC) Lower
- UPDATE: Angelo, Gordon to Acquire Benihana (BNHN) for $16.30/Share in Cash
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Morning MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
